InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by BLATT LAWRENCE. Officer active across 1 company, notably Aligos Therapeutics, Inc.. Aggregated, 1 disclosures have been published. History available since 25 October 2023. The latest transaction was filed on 25 October 2023 (Attribution). Regulator: SEC (Form 4). All data is free.
1 of 1 declaration